Matthey seeks catalyst for Asian expansion

UK chemicals and metals firm Johnson Matthey has opened a precious
metal process catalyst manufacturing plant in India to cater to the
growing demand from the local pharmaceutical industry and provide a
springboard into other Asian markets.

The plant, at Taloja in the western state of Maharashtra, was set up with an investment of about 250 million rupees (€1.9m), and is Johnson Matthey's tenth process catalyst manufacturing plant.

Johnson Matthey​ has been making autocatalysts in India since 1998 and acquired ICI India's catalyst business in 2002 to get a foothold in the base metal catalyst field in the country.

The company told local newspaper The Hindu that the company is aiming for a 10 to 15 per cent growth annually in the catalyst sector of the pharma industry.

"This new facility complements our existing presence and reflects our commitment to this rapidly growing economy,"​ said Neil Carson, executive director of Johnson Matthey. For example, the company has been active in the autocatalysts sector in India since setting up a manufacturing plant in 1998.

Related news

Related products

show more

Solution for challenging antibodies – Planova™ S20N

Solution for challenging antibodies – Planova™ S20N

Content provided by Asahi Kasei Medical Co., Ltd. | 24-Sep-2024 | White Paper

Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration performance for challenging molecules...

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us

Products

View more

Webinars